Navigation path

Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information

Nimorazole maleate

EU orphan designation number: EU/3/12/952   
Active ingredient: Nimorazole maleate
Indication: Treatment of squamous cell carcinoma of the head and neck in patients undergoing radiotherapy
Sponsor: Conventia Medical LLP
First Floor, St Peters House, Market Place, Tring, Herts HP23 5AE, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/02/2012 Orphan designation EMA/OD/099/11 (2012)878 of 9/02/2012